These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17297445)

  • 21. Resistance to imatinib of bcr/abl p190 lymphoblastic leukemia cells.
    Mishra S; Zhang B; Cunnick JM; Heisterkamp N; Groffen J
    Cancer Res; 2006 May; 66(10):5387-93. PubMed ID: 16707466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic characterization of a BCR-ABL transduced mouse cell line.
    Rudolph C; Hegazy AN; von Neuhoff N; Steinemann D; Schröck E; Stripecke R; Klein C; Schlegelberger B
    Cancer Genet Cytogenet; 2005 Aug; 161(1):51-6. PubMed ID: 16080957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JunB inhibits proliferation and transformation in B-lymphoid cells.
    Szremska AP; Kenner L; Weisz E; Ott RG; Passegué E; Artwohl M; Freissmuth M; Stoxreiter R; Theussl HC; Parzer SB; Moriggl R; Wagner EF; Sexl V
    Blood; 2003 Dec; 102(12):4159-65. PubMed ID: 12907453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation.
    Beer-Hammer S; Zebedin E; von Holleben M; Alferink J; Reis B; Dresing P; Degrandi D; Scheu S; Hirsch E; Sexl V; Pfeffer K; Nürnberg B; Piekorz RP
    J Leukoc Biol; 2010 Jun; 87(6):1083-95. PubMed ID: 20200404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of transcriptionally active Jun proteins regulates drug-induced senescence.
    Yogev O; Anzi S; Inoue K; Shaulian E
    J Biol Chem; 2006 Nov; 281(45):34475-83. PubMed ID: 16966326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage.
    Passegué E; Jochum W; Schorpp-Kistner M; Möhle-Steinlein U; Wagner EF
    Cell; 2001 Jan; 104(1):21-32. PubMed ID: 11163237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle promoting activity of JunB through cyclin A activation.
    Andrecht S; Kolbus A; Hartenstein B; Angel P; Schorpp-Kistner M
    J Biol Chem; 2002 Sep; 277(39):35961-8. PubMed ID: 12121977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf.
    Signer RA; Montecino-Rodriguez E; Witte ON; Dorshkind K
    Genes Dev; 2008 Nov; 22(22):3115-20. PubMed ID: 19056891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-JUN prevents methylation of p16(INK4a) (and Cdk6): the villain turned bodyguard.
    Kollmann K; Heller G; Sexl V
    Oncotarget; 2011 May; 2(5):422-7. PubMed ID: 21789792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Arf-inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin-1, JunB and Egr1.
    Mallakin A; Sugiyama T; Kai F; Taneja P; Kendig RD; Frazier DP; Maglic D; Matise LA; Willingham MC; Inoue K
    Int J Cancer; 2010 Mar; 126(6):1403-16. PubMed ID: 19816943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene.
    Le LQ; Kabarowski JH; Wong S; Nguyen K; Gambhir SS; Witte ON
    Cancer Cell; 2002 May; 1(4):381-91. PubMed ID: 12086852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus.
    Zimmerman RS; Rosenberg N
    J Virol; 2008 Sep; 82(17):8383-91. PubMed ID: 18579612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2.
    Mishra S; Pertz V; Zhang B; Kaur P; Shimada H; Groffen J; Kazimierczuk Z; Pinna LA; Heisterkamp N
    Leukemia; 2007 Jan; 21(1):178-80. PubMed ID: 17082777
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of JunB in erythroid differentiation.
    Jacobs-Helber SM; Abutin RM; Tian C; Bondurant M; Wickrema A; Sawyer ST
    J Biol Chem; 2002 Feb; 277(7):4859-66. PubMed ID: 11726656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meis1 disrupts the genomic imprint of Dlk1 in a NUP98-HOXD13 leukemia model.
    Argiropoulos B; Palmqvist L; Imren S; Miller M; Rouhi A; Mager DL; Humphries RK
    Leukemia; 2010 Oct; 24(10):1788-91. PubMed ID: 20739957
    [No Abstract]   [Full Text] [Related]  

  • 36. Leukemic challenge unmasks a requirement for PI3Kdelta in NK cell-mediated tumor surveillance.
    Zebedin E; Simma O; Schuster C; Putz EM; Fajmann S; Warsch W; Eckelhart E; Stoiber D; Weisz E; Schmid JA; Pickl WF; Baumgartner C; Valent P; Piekorz RP; Freissmuth M; Sexl V
    Blood; 2008 Dec; 112(12):4655-64. PubMed ID: 18684865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SLUG in cancer development.
    Pérez-Mancera PA; González-Herrero I; Pérez-Caro M; Gutiérrez-Cianca N; Flores T; Gutiérrez-Adán A; Pintado B; Sánchez-Martín M; Sánchez-García I
    Oncogene; 2005 Apr; 24(19):3073-82. PubMed ID: 15735690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A non-coding cationic lipid DNA complex produces lasting anti-leukemic effects.
    Keasey N; Herse Z; Chang S; Liggitt DH; Lay M; Fairman J; Claxton DF
    Cancer Biol Ther; 2010 Sep; 10(6):625-31. PubMed ID: 20647744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Establishment of a mouse model for detecting multi-drug resistant minimal residual leukemia cells expressing green fluorescent protein].
    Xu XP; Fei XH; Chen L; Lu SQ; Gao L; Ni X; Xu XW; Jia XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1014-7. PubMed ID: 16403270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis.
    Kollmann K; Heller G; Schneckenleithner C; Warsch W; Scheicher R; Ott RG; Schäfer M; Fajmann S; Schlederer M; Schiefer AI; Reichart U; Mayerhofer M; Hoeller C; Zöchbauer-Müller S; Kerjaschki D; Bock C; Kenner L; Hoefler G; Freissmuth M; Green AR; Moriggl R; Busslinger M; Malumbres M; Sexl V
    Cancer Cell; 2013 Aug; 24(2):167-81. PubMed ID: 23948297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.